(Q36803956)

16 August 2017

Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis (English)

1 reference

16 August 2017

0 references

1 reference

1 reference

R Rustomjee

1

1 reference

16 August 2017

A H Diacon

2

1 reference

16 August 2017

J Allen

3

1 reference

16 August 2017

A Venter

4

1 reference

16 August 2017

C Reddy

5

1 reference

16 August 2017

R F Patientia

6

1 reference

16 August 2017

T C P Mthiyane

7

1 reference

16 August 2017

T De Marez

8

1 reference

16 August 2017

R van Heeswijk

9

1 reference

16 August 2017

R Kerstens

10

1 reference

16 August 2017

A Koul

11

1 reference

16 August 2017

K De Beule

12

1 reference

16 August 2017

P R Donald

13

1 reference

16 August 2017

D F McNeeley

14

1 reference

16 August 2017

language of work or name

English

0 references

publication date

27 May 2008

1 reference

Antimicrobial Agents and Chemotherapy

16 August 2017

1 reference

16 August 2017

52

1 reference

16 August 2017

8

1 reference

16 August 2017

2831-2835

1 reference

Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Diarylquinolines target subunit c of mycobacterial ATP synthase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Early bactericidal activity of antituberculosis agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

M. tuberculosis persistence, latency, and drug tolerance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The curious characteristics of pyrazinamide: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

The global tuberculosis situation and the new control strategy of the World Health Organization

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Preliminary study on rapid identification of Mycobacterium tuberculosis complex isolates by the BD ProbeTec ET system

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2493110

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18505852

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18505852

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18505852

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.01204-07

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18505852

1 reference